Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Sar439859
2. 2114339-57-8
3. Sar-439859
4. Amcenestrant [inn]
5. Amcenestrant [usan]
6. Tbf1nhy02o
7. (s)-8-(2,4-dichlorophenyl)-9-(4-((1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)phenyl)-6,7-dihydro-5h-benzo[7]annulene-3-carboxylic Acid
8. 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic Acid
9. 8-(2,4-dichlorophenyl)-9-[4-[[(3s)-1-(3-fluoropropyl)-3-pyrrolidinyl]oxy]phenyl]-6,7-dihydro-5h-benzocycloheptene-3-carboxylic Acid
10. 5h-benzocycloheptene-3-carboxylic Acid, 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)-3-pyrrolidinyl)oxy)phenyl)-6,7-dihydro-
11. 6-(2,4-dichlorophenyl)-5-[4-[(3~{s})-1-(3-fluoranylpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7~{h}-benzo[7]annulene-2-carboxylic Acid
12. 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)-3-pyrrolidinyl)oxy)phenyl)-6,7-dihydro-5h-benzocycloheptene-3-carboxylic Acid
13. Unii-tbf1nhy02o
14. Amcenestrant [jan]
15. Amcenestrant [who-dd]
16. Chembl4475463
17. Schembl19131426
18. Us9714221, Example 51
19. Bdbm263716
20. Ex-a4678
21. Nsc827675
22. S9609
23. Who 11312
24. Nsc-827675
25. Hy-133017
26. Cs-0109407
27. Q66885452
28. 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)phenyl)-6,7-dihydro-5h-benzo(7)annulene-3-carboxylic Acid
29. L5b
| Molecular Weight | 554.5 g/mol |
|---|---|
| Molecular Formula | C31H30Cl2FNO3 |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | 553.1586774 g/mol |
| Monoisotopic Mass | 553.1586774 g/mol |
| Topological Polar Surface Area | 49.8 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 832 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
61
PharmaCompass offers a list of Amcenestrant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amcenestrant manufacturer or Amcenestrant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amcenestrant manufacturer or Amcenestrant supplier.
PharmaCompass also assists you with knowing the Amcenestrant API Price utilized in the formulation of products. Amcenestrant API Price is not always fixed or binding as the Amcenestrant Price is obtained through a variety of data sources. The Amcenestrant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SAR439859 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SAR439859, including repackagers and relabelers. The FDA regulates SAR439859 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SAR439859 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SAR439859 supplier is an individual or a company that provides SAR439859 active pharmaceutical ingredient (API) or SAR439859 finished formulations upon request. The SAR439859 suppliers may include SAR439859 API manufacturers, exporters, distributors and traders.
SAR439859 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SAR439859 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SAR439859 GMP manufacturer or SAR439859 GMP API supplier for your needs.
A SAR439859 CoA (Certificate of Analysis) is a formal document that attests to SAR439859's compliance with SAR439859 specifications and serves as a tool for batch-level quality control.
SAR439859 CoA mostly includes findings from lab analyses of a specific batch. For each SAR439859 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SAR439859 may be tested according to a variety of international standards, such as European Pharmacopoeia (SAR439859 EP), SAR439859 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SAR439859 USP).
